Lornox 8 mg 30 tablets

Lornox 8 mg 30 tablets

Composition: 

Lornoxicam 8 mg.
Excipients: lactose monohydrate, povidone K25, starch, Avicel, Aerosil.

Product Description:

• Lornoxicam is a non‑steroidal anti‑inflammatory drug (NSAID) from the oxicam class.
• It has pronounced anti‑inflammatory, analgesic, antipyretic, and anti‑platelet effects. 
• The mechanism of action is associated with suppression of prostaglandin synthesis through inhibition of COX‑1 and COX‑2, leading to reduced inflammation and pain. 
• It suppresses both the exudative and proliferative phases of the inflammatory process.

Indications for Use:

• Rheumatoid arthritis.
• Osteoarthritis.
• Ankylosing spondylitis.
• Joint syndrome in acute gout.
• Bursitis, tendovaginitis.
• Moderate to severe pain (arthralgia, myalgia, neuralgia, lumbago, sciatica, migraine, toothache, headache, dysmenorrhea, pain from trauma and burns).
• Fever associated with colds and infectious diseases.

Method of Administration and Dosage:

Orally, 8 mg. If analgesic effect is insufficient, an additional 8 mg may be taken.
Maximum daily dose (oral): 16 mg.

Contraindications:

• Acute gastrointestinal bleeding.
• Peptic ulcer of the stomach or duodenum in the acute phase.
• Ulcerative colitis in the acute phase.
• Bronchial asthma.
• Severe chronic heart failure.
• Hypovolemia.
• Blood clotting disorders (hemophilia, hemorrhagic diathesis, thrombocytopenia).
• Severe hepatic and/or renal failure.
• Glucose‑6‑phosphate dehydrogenase deficiency.
• Cerebral hemorrhage (including suspected).
• Pregnancy and breastfeeding.
• Children and adolescents under 18 years.
• Hypersensitivity to lornoxicam, acetylsalicylic acid, or other NSAIDs.

Precautions:

• Use with caution in patients with a history of erosive‑ulcerative lesions or gastrointestinal bleeding, moderate renal impairment, post‑surgical conditions, elderly patients (over 65 years), and those weighing less than 50 kg.
• Regular monitoring of renal function is required during treatment in patients with renal impairment. 
• Use only after careful assessment of benefit/risk in cases of heart failure, hypertension, liver or kidney dysfunction, fluid retention and edema, or after major surgery.
• Lornoxicam reduces psychomotor reaction speed; caution is advised when driving or operating potentially hazardous machinery during treatment.

Adverse Reactions / Side Effects:

Possible dyspeptic disorders, nausea, abdominal pain.
Rare: allergic reactions, skin rash, itching.
With prolonged use: risk of ulcer formation and gastrointestinal bleeding.

Pregnancy and Lactation:

Contraindicated during pregnancy and breastfeeding.

Storage Conditions:

Store at temperatures not exceeding 30°C, in a dry place.

Packaging:

Cardboard box containing 3 blisters of 10 tablets and instructions.